Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Data needed for haemochromatosis screening:

This article was originally published in Clinica

Executive Summary

Screening for hereditary haemochromatosis should not be introduced until there is good data available to show the extent of associated morbidity, says an editorial in the August 28 issue of the British Medical Journal. However, doctors should be made aware that disease prevalence is more common than previously thought, occurring in as many as five in every 1,000 white people of north European heritage, say the authors.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT079358

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel